Oropharyngeal pain: FDA reporting patterns
91,377 FDA FAERS reports mention Oropharyngeal pain. 45,361 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 6,576 reports
- Etanercept: 5,966 reports
- Dupilumab: 3,302 reports
- Infliximab: 3,103 reports
- Fluticasone: 2,510 reports
- Secukinumab: 2,383 reports
- Methotrexate: 2,095 reports
- Omalizumab: 2,080 reports
- Treprostinil: 1,937 reports
- Tofacitinib: 1,927 reports
- Rituximab: 1,765 reports
- Evolocumab: 1,459 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.